08/03/2026
๐๐ฌ๏ธ Mounjaro (Tirzepatide): Why Respiratory & Sleep Specialists Are Paying Attention
Many chronic lung and sleep conditions are closely linked to weight and metabolic health. Conditions such as obstructive sleep apnoea (OSA), obesity hypoventilation syndrome, asthma, and even some forms of pulmonary hypertension are significantly affected by excess weight.
One medication that has been gaining attention globally is Mounjaro (tirzepatide).
๐ฌ What is Mounjaro?
Mounjaro is an injectable medication originally developed for type 2 diabetes. It works by targeting two hormone pathways (GIP and GLP-1), helping to regulate blood sugar, reduce appetite, and promote meaningful weight loss.
โ๏ธ Why does this matter for lung and sleep health?
Weight reduction can significantly improve:
โข Obstructive sleep apnoea (OSA) โ Weight loss can reduce airway collapse during sleep, lower CPAP pressure requirements, and in some cases reduce OSA severity.
โข Obesity hypoventilation syndrome โ Improved weight can enhance breathing mechanics and oxygenation.
โข Asthma control โ Obesity is associated with more severe, harder-to-control asthma.
โข Breathlessness on exertion โ Less weight reduces the workload on both the lungs and heart.
Emerging evidence suggests that medications like tirzepatide may play an important supportive role in carefully selected patients as part of a comprehensive treatment plan.
โ ๏ธ Important considerations
Mounjaro is not a โquick fixโ and is not suitable for everyone. It requires proper medical evaluation, monitoring, and integration with lifestyle modification, sleep therapy (e.g., CPAP), and respiratory management.
๐ฌ Who should consider asking about it?
Patients with:
โข Moderate to severe OSA with obesity
โข Obesity hypoventilation
โข Difficult-to-control asthma with metabolic syndrome
โข Significant weight-related breathlessness
At our practice, we take an integrated approach to lung, sleep, and metabolic health. Treating the underlying drivers โ not just the symptoms โ often leads to better long-term outcomes.
If you struggle with sleep apnoea, chronic breathlessness, or weight-related lung issues, speak to your doctor about whether newer medical therapies may be appropriate for you.